| Kendall Schwab, PHARMD | |
|
69320 Louisiana 21, Covington, LA 70433 | |
| (985) 875-7916 | |
| Not Available |
| Full Name | Kendall Schwab |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 69320 Louisiana 21, Covington, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154722395 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 020732 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kendall Schwab, PHARMD 69320 Louisiana 21, Covington, LA 70433 Ph: (985) 875-7916 | Kendall Schwab, PHARMD 69320 Louisiana 21, Covington, LA 70433 Ph: (985) 875-7916 |
News Archive
The Los Angeles Times reports that, for Californians, the state's largest insurers are likely to stick with, or even reduce, the size of their doctor networks for the upcoming plan season. Additionally, no comprehensive directory is available to help consumers match their physicians with their health plans. Meanwhile, The Washington Post also explores how the issue is playing out in the context of a ballot initiative.
Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe evaluating the safety and performance of the novel Esprit drug eluting bioresorbable vascular scaffold (BVS) for the treatment of blockages in the superficial femoral arteries (SFA) and iliac arteries that have resulted in claudication.
Exelixis, Inc. announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for XL888, a novel anticancer compound. XL888 is an orally available small molecule inhibitor of HSP90, which is a chaperone protein that promotes the activity and stability of a range of key regulatory proteins, including kinases.
Intellectual Property Watch reports on a roundtable on global health law, innovation, access and justice, hosted last week by the Geneva-based Graduate Institute of International and Development Studies and Georgetown Law School.
Removing a single protein prevents early damage in blood vessels from triggering a later-stage, frequently lethal complication of atherosclerosis, according to research published online today in the journal Nature Medicine. By eliminating the gene for a signaling protein called cyclophilin A (CypA) from a strain of mice, researchers were able to provide complete protection against abdominal aortic aneurysm (AAA).
› Verified 4 days ago
Anh Thi Phuong Tran, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 437 Saddlebrook Ct, Covington, LA 70435 Phone: 504-430-2213 | |
Paula Bates Fricker, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1107 S Tyler St, Covington, LA 70433 Phone: 985-892-0818 Fax: 985-892-2742 | |
Stan Tran, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 69630 Stirling Blvd, Covington, LA 70433 Phone: 985-327-6261 | |
Dr. Nathaniel Schultz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 627 W 21st Ave, Covington, LA 70433 Phone: 985-893-0700 | |
Joseph Lawrence Adams, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1203 Business 190, Covington, LA 70433 Phone: 985-893-7476 Fax: 985-893-5688 | |
Mr. Urban Martinez Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1203 Business 190, Covington, LA 70433 Phone: 985-803-7476 | |
Dr. Geoffrey Paul Gros, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 N Highway 190, Covington, LA 70433 Phone: 985-327-6315 Fax: 985-327-6316 |